$AVTX stock has now fallen 12% today, according to our price data from Polygon. There has been approximately $24,304,548 of trading volume.
It has been the 993rd most-searched ticker on Quiver Quantitative over the last day, out of 12,891 total tickers searched.
Here is what we see in our data on $AVTX (you can track the company live on Quiver's $AVTX stock page):
$AVTX Insider Trading Activity
$AVTX insiders have traded $AVTX stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $AVTX stock by insiders over the last 6 months:
- MITTIE DOYLE (Chief Medical Officer) has made 0 purchases and 9 sales selling 138,375 shares for an estimated $2,724,345.
- PAUL VARKI (Chief Legal Officer) has made 0 purchases and 5 sales selling 75,063 shares for an estimated $1,513,673.
- CHRISTOPHER RYAN SULLIVAN (Chief Financial Officer) has made 0 purchases and 11 sales selling 79,874 shares for an estimated $1,441,904.
- MITCHELL CHAN sold 3,167 shares for an estimated $72,460
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$AVTX Hedge Fund Activity
We have seen 62 institutional investors add shares of $AVTX stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 2,659,181 shares (+1207.1%) to their portfolio in Q1 2026, for an estimated $39,701,572
- AVORO CAPITAL ADVISORS LLC added 1,410,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,051,300
- FARALLON CAPITAL MANAGEMENT LLC added 916,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $13,675,880
- RTW INVESTMENTS, LP added 856,962 shares (+inf%) to their portfolio in Q1 2026, for an estimated $12,794,442
- CALIGAN PARTNERS LP added 753,490 shares (+85.5%) to their portfolio in Q1 2026, for an estimated $11,249,605
- ORBIMED ADVISORS LLC removed 712,135 shares (-60.0%) from their portfolio in Q1 2026, for an estimated $10,632,175
- UBS GROUP AG added 664,164 shares (+139.0%) to their portfolio in Q1 2026, for an estimated $9,915,968
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$AVTX Analyst Ratings
Wall Street analysts have issued reports on $AVTX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 05/06/2026
- Guggenheim issued a "Buy" rating on 02/02/2026
- HC Wainwright & Co. issued a "Buy" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 12/18/2025
To track analyst ratings and price targets for $AVTX, check out Quiver Quantitative's $AVTX forecast page.
$AVTX Price Targets
Multiple analysts have issued price targets for $AVTX recently. We have seen 9 analysts offer price targets for $AVTX in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Joseph Catanzaro from Mizuho set a target price of $45.0 on 05/14/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $35.0 on 05/14/2026
- Jason N. Butler from Citizens set a target price of $55.0 on 05/14/2026
- Robert Driscoll from Wedbush set a target price of $34.0 on 05/14/2026
- Yasmeen Rahimi from Piper Sandler set a target price of $60.0 on 05/11/2026
- Julian Harrison from BTIG set a target price of $58.0 on 05/06/2026
- Andy Chen from Wolfe Research set a target price of $48.0 on 04/09/2026
You can track data on $AVTX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
